Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.
Dilraj
A
A
Center for Epidemiological Research in South Africa, Medical Research Council, Congella. dilraja@mrc.ac.za
Cutts
F T
FT
Bennett
J V
JV
Fernandez de Castro
J
J
Cohen
B
B
Coovadia
H M
HM
D000280:Administration, Inhalation; D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007117:Immunization, Secondary; D007279:Injections, Subcutaneous; D008297:Male; D008457:Measles / Q000517:prevention & control; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000276:immunology*; D008459:Measles virus / Q000276:immunology*; D013997:Time Factors
D000914:Antibodies, Viral; D008458:Measles Vaccine